Hesperetin attenuates hypoxia/reoxygenation‑induced injury in renal tubular epithelial cells
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
ObjectiveTo investigate whether hesperetin(HES) alleviates hypoxia/reoxygenation(H/R)‑induced injury in renal tubular epithelial cells by modulating the peroxisome proliferator‑activated receptor γ (PPARγ)/nuclear factor κB (NF‑κB) signaling pathway.MethodsHuman renal cortex proximal tubule epithelial (HK2) cells were assigned to five groups: control, HES‑30 (30 μM HES), HES‑60 (60 μM HES), HES‑90 (90 μM HES), and HES‑90+PPARγ inhibitor(GW9662; 90 μM HES +5 μM GW9662). Except for the control group, all groups were subjected to H/R to model renal ischemia⁃reperfusion injury. Cell viability and LDH activity were measured using CCK‑8 and LDH assay kits, respectively. Apoptosis was assessed by flow cytometry. TNF‑α, IL‑1β and IL‑6 were quantified by ELISA. MDA, SOD and GSH‑Px were measured using commercial kits. Western blot was used to determine expression of Cox‑2, Nox2, Bcl‑2, Bax, PPARγ and p‑NF‑κB.ResultsCompared with the control group, the H/R group showed significant decreases in HK2 cell viability, SOD and GSH‑Px activities, Bcl‑2 protein expression and p‑PPARγ/PPARγ values [100% vs. (45.55±5.21)%, (157.21±13.33)×103 U/L vs. (48.74±4.55)×103 U/L, (60.16±6.89)×10-3 mmol/L vs. (19.77±2.16)×10-3 mmol/L, (0.97±0.11) vs. (0.23±0.03), (1.05±0.11) vs. (0.25±0.03)] (P
Fields of Study & Subjects
Acute Kidney Injury Research
Chemotherapy-induced organ toxicity mitigation
Flavonoids in Medical Research
Publication details
- Journal / source
- DOAJ (DOAJ: Directory of Open Access Journals)
- Publication date
- 1 March 2026
- Language
- ZH